OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Clinical trial NCT00382811 · COMPLETED
Trial details
- NCT number
- NCT00382811
- Sponsor
- MEI Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2009-04-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.